Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DP

Diana Graus Porta — 8 Patents

Basel, CH: #246 of 1,913 inventorsTop 15%
Overall (All Time): #600,572 of 4,157,543Top 15%
8 Patents All Time
Diana Graus Porta has been granted 8 US patents. The first was granted in 2012 and the most recent in January 2022. Diana Graus Porta ranks #600,572 of 4,157,543 US inventors in our database (top 14.4%). Patent records list Diana Graus Porta in Basel, CH.

Patents per Year

Patents granted per year, 2012 to 2022Bar chart with a peak of 2 patents in 2014.peak 22012: 1 patents20122013: 1 patents20132014: 2 patents20142018: 2 patents20182019: 1 patents20192022: 1 patents2022

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11229643 Combinations of FGFR4 inhibitors and bile acid sequestrants Robin Alec Fairhurst, Jacqueline Kinyamu-Akunda, Andreas Mahl, Luigi Manenti, Andreas WEISS +2 more 2022-01-25 $24,561,000
10507201 Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors Nicole Buschmann, Robin Alec Fairhurst, Pascal Furet, Carolina Haefliger, Bo Han +14 more 2019-12-17 $17,613,000
10130629 Pharmaceutical combinations Nicole Buschmann, Robin Alec Fairhurst, Jorge Garcia Fortanet, Pascal Furet, Nafeeza Hafeez +11 more 2018-11-20 $43,405,000
10028955 FGFR inhibitor for use in the treatment of hypophosphatemic disorders Michaela Kneissel, Vito Guagnano, Simon Wöhrle 2018-07-24 $14,720,000
8815901 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors Pascal Furet, Vito Guagnano 2014-08-26 $14,069,000
8674099 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors Pascal Furet, Vito Guagnano 2014-03-18 $5,753,000
8536175 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors Pascal Furet, Vito Guagnano 2013-09-17 $10,029,000
8273882 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors Pascal Furet, Vito Guagnano 2012-09-25 $12,273,000